{"id":"W4385702649","doi":"10.1097/01.hs9.0000975280.98608.35","title":"PB2129: THE MODAKAFUSP ALFA IINNOVATE CLINICAL DEVELOPMENT PROGRAM: RATIONALE AND DESIGN OF 3 PHASE 1/2 TRIALS OF AN INNATE IMMUNITY ENHANCER FOR MULTIPLE MYELOMA (MM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Daratumumab; CD38; Multiple myeloma; Medicine; Monoclonal antibody; Innate immune system; Acquired immune system; Immunology; Cancer research; Immune system; Antibody; Biology; Stem cell; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004244028,0.0001495866,0.0006508349,0.00005728468,0.0001511646,0.00001310702,0.0001454896,0.0001022485,0.0001953156],"category_scores_gemma":[0.001363695,0.00009151662,0.0001335815,0.0003621951,0.0002671827,0.00006383646,0.00009911201,0.0001898746,0.000008492605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001409054,"about_ca_system_score_gemma":0.0003731915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004166631,"about_ca_topic_score_gemma":0.00003030406,"domain_scores_codex":[0.997698,0.0003615697,0.001070984,0.0002327954,0.0003685099,0.0002681324],"domain_scores_gemma":[0.997005,0.00196466,0.0002860562,0.0002574835,0.0003734769,0.0001132797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01112412,0.002410179,0.002876244,0.001056564,0.0007203107,0.00001952611,0.001479493,0.00005249539,0.1310898,0.0006160949,0.004322368,0.8442328],"study_design_scores_gemma":[0.027878,0.007613459,0.04361844,0.0006739255,0.0002776963,0.00004159899,0.001932549,0.04840027,0.7193879,0.002394702,0.1471983,0.0005831259],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936993,0.0005514792,0.001624914,0.0009821048,0.00008054142,0.002797036,0.00009877556,0.00003951963,0.0001264042],"genre_scores_gemma":[0.9592929,0.0004609767,0.0354299,0.000127145,0.000221132,0.0006860847,0.0004007424,0.00003332127,0.003347758],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8436497,"threshold_uncertainty_score":0.3731939,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3024710832364378,"score_gpt":0.4907221087897801,"score_spread":0.1882510255533422,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}